Work

A Phase II trial of Hypofractionated Proton Therapy in Prostate Cancer: 3-year Physician and Patient Reported Outcomes

Year: 2019

Type: article

Study design: Clinical Trial

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2019.06.1857

Authors: N. Philip, T.J. Pugh, R. Ye, H. Hwang, X. Wang, S.J. Shah, S. Choi, U. Mahmood, Q.N. Nguyen, S.G. Chun, L.L. Mayo, A.K. Lee, C. Tang, M.S. Anscher, K.E. Hoffman, D.A. Kuban, J.W. Davis, P. Troncoso, H. Choi, S.J. Frank

Institutions: The University of Texas MD Anderson Cancer Center, University of Colorado Denver

Language: English

Topic: Prostate Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2973167766

FWCI:

Cites:

Cited by:

Related to: 10